Zhiming Wang

1.6k total citations
65 papers, 1.2k citations indexed

About

Zhiming Wang is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhiming Wang has authored 65 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 17 papers in Surgery and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhiming Wang's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Gastric Cancer Management and Outcomes (5 papers). Zhiming Wang is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Gastric Cancer Management and Outcomes (5 papers). Zhiming Wang collaborates with scholars based in China, Japan and United States. Zhiming Wang's co-authors include Xinying Li, Yiming Tao, Zhejia Zhang, Zhongxia Wu, Jiasheng Song, Shutang Zhou, Shun Deng, Jieshou Li, Wei Jiang and Zhiwei Jiang and has published in prestigious journals such as Analytical Chemistry, Clinical Infectious Diseases and Journal of Neurochemistry.

In The Last Decade

Zhiming Wang

59 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhiming Wang China 21 607 405 213 204 142 65 1.2k
Yi Xie China 21 759 1.3× 279 0.7× 126 0.6× 139 0.7× 178 1.3× 59 1.3k
Herbert Schramek Austria 26 880 1.4× 199 0.5× 176 0.8× 134 0.7× 223 1.6× 51 1.7k
Lijun Huang China 18 456 0.8× 185 0.5× 148 0.7× 61 0.3× 63 0.4× 66 971
Yufeng Yao China 24 798 1.3× 378 0.9× 148 0.7× 142 0.7× 132 0.9× 52 1.5k
Song Wei China 20 757 1.2× 430 1.1× 117 0.5× 78 0.4× 154 1.1× 34 1.2k
Franck Galland France 22 831 1.4× 144 0.4× 100 0.5× 82 0.4× 192 1.4× 42 1.4k
Hirotaka Matsumoto Japan 20 511 0.8× 120 0.3× 137 0.6× 198 1.0× 70 0.5× 99 1.4k
Yuan Shi China 16 780 1.3× 448 1.1× 198 0.9× 80 0.4× 104 0.7× 50 1.5k
Guiying Wang China 22 1.2k 1.9× 512 1.3× 190 0.9× 143 0.7× 330 2.3× 100 1.7k

Countries citing papers authored by Zhiming Wang

Since Specialization
Citations

This map shows the geographic impact of Zhiming Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiming Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiming Wang more than expected).

Fields of papers citing papers by Zhiming Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiming Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiming Wang. The network helps show where Zhiming Wang may publish in the future.

Co-authorship network of co-authors of Zhiming Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiming Wang. A scholar is included among the top collaborators of Zhiming Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiming Wang. Zhiming Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shuangyi, Yujie Wei, Yu Tang, et al.. (2025). Calpain-1 is required for abnormality of liver function and metabolism in apolipoprotein E knockout mouse evaluated noninvasively by small animal MRI and PET-CT. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1870(5). 159616–159616.
2.
Shen, Meixiao, et al.. (2024). Pernicious anemia is a common cause of cobalamin deficiency-caused megaloblastic anemia in Hainan, China. Hematology. 29(1). 2399375–2399375.
3.
Shen, Meixiao, et al.. (2023). The outcome and the risk factors of mucormycosis among patients with hematological diseases: a systematic and meta-analysis. Frontiers in Medicine. 10. 1268840–1268840. 7 indexed citations
4.
Li, Juanni, et al.. (2021). Prognostic Value of PLXND1 and TGF-β1 Coexpression and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma. Frontiers in Oncology. 10. 604131–604131. 13 indexed citations
5.
Bai, Ning, Xingsheng Qiu, Ning Lyu, et al.. (2018). circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346. Journal of Experimental & Clinical Cancer Research. 37(1). 172–172. 133 indexed citations
6.
Wang, Zhiming, et al.. (2017). NEAT1 promotes cell proliferation and invasion in hepatocellular carcinoma by negative regulating miR-613 expression. Biomedicine & Pharmacotherapy. 94. 612–618. 41 indexed citations
7.
Wang, Hua, Jianfu Wang, Xinrong Wang, et al.. (2016). Association analysis of CAST gene polymorphism with meat quality in five sheep breeds. 28(8). 1314. 2 indexed citations
8.
Wang, Zhiming, et al.. (2016). Isolated double adrenocorticotropic hormone-secreting pituitary adenomas: A case report and review of the literature. Oncology Letters. 12(1). 585–590. 9 indexed citations
9.
Xia, Fada, et al.. (2014). Differential Expression of IQGAP1/2 in Hepatocellular Carcinoma and its Relationship with Clinical Outcomes. Asian Pacific Journal of Cancer Prevention. 15(12). 4951–4956. 25 indexed citations
10.
Zhou, Peng, Kemin Wu, Wei Jiang, et al.. (2012). Overexpression of MMSET is Correlation with Poor Prognosis in Hepatocellular Carcinoma. Pathology & Oncology Research. 19(2). 303–309. 25 indexed citations
11.
Jiang, Wei, et al.. (2011). High-mobility Group Box 1 is Associated with Clinicopathologic Features in Patients with Hepatocellular Carcinoma. Pathology & Oncology Research. 18(2). 293–298. 25 indexed citations
12.
Jiang, Wei, Zhiming Wang, Xinying Li, et al.. (2011). Reduced High-Mobility Group Box 1 Expression Induced by RNA Interference Inhibits the Bioactivity of Hepatocellular Carcinoma Cell Line HCCLM3. Digestive Diseases and Sciences. 57(1). 92–98. 16 indexed citations
13.
Li, Ning, Xuegong Fan, Hongbo Liu, et al.. (2009). Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues. Journal of Experimental & Clinical Cancer Research. 28(1). 122–122. 24 indexed citations
14.
Wang, Zhiming. (2008). Prospective randomized study of abdominal drains in gastric cancer surgery. 8 indexed citations
15.
Tan, Hui Min, et al.. (2008). CD147 expression as a significant prognostic factor in differentiated thyroid carcinoma. Translational research. 152(3). 143–149. 31 indexed citations
16.
Williams, Gregory C., Ming‐yi Hu, Thomas Zimmerman, et al.. (2006). The Impact of Posture on Cardiac Repolarization: More Than Heart Rate?. Journal of Cardiovascular Electrophysiology. 17(4). 352–358. 17 indexed citations
17.
Jang, Il‐Sung, Malcolm S. Brodwick, Zhiming Wang, et al.. (2006). The Na+/H+ exchanger is a major pH regulator in GABAergic presynaptic nerve terminals synapsing onto rat CA3 pyramidal neurons. Journal of Neurochemistry. 99(4). 1224–1236. 33 indexed citations
18.
Wang, Zhiming. (2002). Surgical treatment of thyroid cancer(a report of 246 cases). Zhonghua putong waike zazhi.
19.
Wang, Zhiming. (2000). A Comprehensive Curative Effect of Malignant Brain Tumors Treated with VM26+MeCCNU and TCM. Zhongliu fangzhi yanjiu. 27(2). 152–153. 1 indexed citations
20.
Wang, Xiaorong, et al.. (1995). Effects of Smoking on Respiratory Function and Exercise Performance in Asbestos Workers.. Industrial Health. 33(4). 173–180. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi Xie Breakdown of academic impact, for papers by Herbert Schramek Breakdown of academic impact, for papers by Lijun Huang Breakdown of academic impact, for papers by Yufeng Yao Breakdown of academic impact, for papers by Song Wei Breakdown of academic impact, for papers by Franck Galland Breakdown of academic impact, for papers by Hirotaka Matsumoto Breakdown of academic impact, for papers by Yuan Shi Breakdown of academic impact, for papers by Guiying Wang
Rankless by CCL
2026